The coronavirus seems to be in retreat in the United States, with the number of cases across the country down about 25 percent compared with a couple of weeks ago. Hospitalizations and deaths are also falling.So, what stage are we in with the pandemic? And how will developments such as a new antiviral treatment and the availability of booster shots affect things?Guest: Apoorva Mandavilli, a science and global health reporter for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: The authorization for booster shots applies to groups of people in the United States fully vaccinated with the Pfizer vaccine, but about 45 percent of the country’s fully inoculated people received Moderna or Johnson & Johnson doses.Merck said it would seek authorization for molnupiravir, an antiviral pill that the company says is effective against Covid. Experts said such treatments could be a powerful tool against the virus.Despite a fall in new cases, hospitalizations and deaths, public health officials said the pandemic remained a potent threat.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Nachrichten
The Daily Folgen
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, six days a week, ready by 6 a.m. Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.
Folgen von The Daily
3010 Folgen
-
Folge vom 07.10.2021The State of the Pandemic
-
Folge vom 06.10.2021The Facebook Whistle-Blower TestifiesThe Senate testimony of Frances Haugen on Tuesday was an eagerly awaited event.Last month, Ms. Haugen, a former Facebook product manager, leaked internal company documents to The Wall Street Journal that exposed the social media giant’s inner workings.How will Ms. Haugen’s insights shape the future of internet regulation?Guest: Sheera Frenkel, a technology reporter for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Ms. Haugen told how Facebook deliberately made efforts to keep users — including children — hooked to its service.Here are other key takeaways from her testimony.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
-
Folge vom 05.10.2021The Most Important Supreme Court Term in DecadesThe latest term of the U.S. Supreme Court will include blockbuster cases on two of the most contentious topics in American life: abortion and gun rights.The cases come at a time when the court has a majority of Republican appointees and as it battles accusations of politicization.Why is the public perception of the court so important? And how deeply could the coming rulings affect the fabric of American society?Guest: Adam Liptak, a reporter covering the United States Supreme Court for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: The Supreme Court’s highly charged docket will test the leadership of Chief Justice John G. Roberts Jr., who has said that he prefers to guide the court toward consensus and incrementalism.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
-
Folge vom 04.10.2021What’s Behind the Ivermectin Frenzy?Ivermectin is a drug that emerged in the 1970s, used mainly for deworming horses and other livestock.But during the pandemic, it has been falsely lauded in some corners as a kind of miracle cure for the coronavirus.What is fueling the demand for a drug that the medical establishment has begged people not to take?Guest: Emma Goldberg, a writer for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Public health warnings against using the anti-parasitic ivermectin as a treatment for Covid-19 appear to have made little progress in stemming its popularity in parts of the United States.Veterinarians, ranchers and farmers say they are struggling with the effects of the surging demand for the drug.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.